DK1803718T3 - 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter - Google Patents

4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter

Info

Publication number
DK1803718T3
DK1803718T3 DK07006697T DK07006697T DK1803718T3 DK 1803718 T3 DK1803718 T3 DK 1803718T3 DK 07006697 T DK07006697 T DK 07006697T DK 07006697 T DK07006697 T DK 07006697T DK 1803718 T3 DK1803718 T3 DK 1803718T3
Authority
DK
Denmark
Prior art keywords
tetrazolyl
pain
treatment
phenylpiperidine derivatives
phenylpiperidine
Prior art date
Application number
DK07006697T
Other languages
Danish (da)
English (en)
Inventor
Zhengming Chen
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1803718T3 publication Critical patent/DK1803718T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK07006697T 2002-11-18 2003-11-17 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter DK1803718T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42738102P 2002-11-18 2002-11-18
US46027803P 2003-04-03 2003-04-03
US48848803P 2003-07-17 2003-07-17
US10/714,066 US7202259B2 (en) 2002-11-18 2003-11-13 Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (fr) 2002-11-18 2003-11-17 Derives de 4-tetrazolyl-4-phenylpiperidine utilises pour le traitement de la douleur

Publications (1)

Publication Number Publication Date
DK1803718T3 true DK1803718T3 (da) 2008-10-27

Family

ID=32777221

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07006697T DK1803718T3 (da) 2002-11-18 2003-11-17 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK03789796T DK1562932T3 (da) 2002-11-18 2003-11-17 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03789796T DK1562932T3 (da) 2002-11-18 2003-11-17 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter

Country Status (36)

Country Link
US (3) US7202259B2 (fr)
EP (2) EP1562932B9 (fr)
JP (2) JP4601429B2 (fr)
KR (1) KR20050115221A (fr)
CN (2) CN100567288C (fr)
AP (1) AP2210A (fr)
AR (1) AR047008A1 (fr)
AT (2) ATE358674T1 (fr)
AU (2) AU2003294313B2 (fr)
BR (1) BR0316305A (fr)
CA (1) CA2506242C (fr)
CO (1) CO5690588A2 (fr)
CR (2) CR7877A (fr)
CY (2) CY1107682T1 (fr)
DE (2) DE60313021T2 (fr)
DK (2) DK1803718T3 (fr)
EA (1) EA008621B1 (fr)
EC (1) ECSP055840A (fr)
ES (2) ES2285235T3 (fr)
GE (1) GEP20084539B (fr)
IL (1) IL209352A0 (fr)
IS (2) IS2720B (fr)
MA (1) MA27565A1 (fr)
ME (1) MEP48108A (fr)
MX (1) MXPA05004669A (fr)
MY (1) MY135647A (fr)
NI (1) NI200500087A (fr)
NO (1) NO20052894L (fr)
NZ (2) NZ572685A (fr)
OA (1) OA13010A (fr)
PT (2) PT1803718E (fr)
RS (1) RS51047B (fr)
SG (1) SG165998A1 (fr)
SI (2) SI1562932T1 (fr)
TW (2) TWI343917B (fr)
WO (1) WO2004046132A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
RS20050812A (sr) 2003-04-30 2007-12-31 Purdue Pharma L.P., Transdermalni dozni oblik otporan na promene
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
KR100886002B1 (ko) 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
PT1951718E (pt) * 2005-11-21 2012-05-21 Purdue Pharma Lp Compostos de 4-oxadiazolil-piperidina e as suas utilizações
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2011056561A1 (fr) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Procédés et compositions pour la génération et l'utilisation d'anticorps spécifiques à une conformation
ES2566828T3 (es) 2010-09-21 2016-04-15 Purdue Pharma L.P. Análogos de buprenorfina como agonistas y/o antagonistas del receptor opioide
CN102648915B (zh) * 2011-02-28 2015-04-15 鲁南制药集团股份有限公司 一种治疗或预防神经病理性疼痛的药物组合物
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
EP2917182B1 (fr) 2012-11-09 2018-01-03 Purdue Pharma LP Analogues de benzomorphane et leur utilisation
WO2014087226A1 (fr) 2012-12-07 2014-06-12 Purdue Pharma L.P. Analogues de buprénorphine en tant que modulateurs d'un récepteur des opioïdes
WO2014091297A1 (fr) 2012-12-14 2014-06-19 Purdue Pharma L.P. Morphinanes spirocycliques et leur utilisation
EP2931724B1 (fr) 2012-12-14 2017-01-25 Purdue Pharma LP Analogues de pyridonemorphinane et activité biologique sur des récepteurs des opioïdes
JP6182620B2 (ja) 2013-01-31 2017-08-16 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097545A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Morphinanes oxabicyclo[2.2.2]octane modulateurs des récepteurs aux opiacés
WO2015097546A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Composés à base de propellane et utilisation de ces derniers en qualité de modulateurs de récepteurs d'opioïdes
WO2015097547A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Hydantoïnes de morphinane substitués en position 10
WO2015097548A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Analogues 7-bêta-alkyle d'orvinols
EP3087057A4 (fr) 2013-12-26 2017-06-28 Purdue Pharma LP Morphinanes à cycle contracté et leur utilisation
WO2015099863A1 (fr) 2013-12-27 2015-07-02 Purdue Pharma L.P. Analogues de la morphinane 6-substitués et 7-substitués, et leurs utilisations
CA2950567A1 (fr) 2014-05-27 2015-12-03 Purdue Pharma L.P. Morphinanes spirocycliques et utilisation associee
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
US11529340B2 (en) 2016-03-22 2022-12-20 Regents Of The University Of Minnesota Combination for treating pain
UA124972C2 (uk) 2016-07-29 2021-12-22 Янссен Фармацевтика Нв Способи лікування раку передміхурової залози
WO2018125716A1 (fr) 2017-01-02 2018-07-05 Purdue Pharma L.P. Dérivés de morphinane et leur utilisation
MX2023013514A (es) * 2021-05-21 2024-04-02 Purdue Pharma Lp Metodos para tratar la cistitis intersticial/sindrome de dolor en la vejiga.
KR20250026332A (ko) * 2022-06-24 2025-02-25 퍼듀 퍼머 엘피 과민성 방광 증후군의 치료 또는 예방 방법

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (fr) 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DK162087D0 (da) * 1987-03-31 1987-03-31 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en) 1992-07-31 1995-09-12 Correa; Paulo N. Energy conversion system
US5606037A (en) 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US6166085A (en) 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
ES2247604T3 (es) * 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
WO1997024325A1 (fr) 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DERIVES DE DIPHENYLMETHANE UTILISES COMME ANTAGONISTES DU RECEPTEUR MIP-1α/RANTES
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
EP1058684A1 (fr) 1998-03-06 2000-12-13 Janssen Pharmaceutica N.V. Inhibiteurs du transport de la glycine
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
ATE278674T1 (de) 1999-03-12 2004-10-15 Boehringer Ingelheim Pharma Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
WO2001021169A1 (fr) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Antagonistes de l'hormone de concentration de la melanine
CA2324330A1 (fr) 1999-11-08 2001-05-08 Ssp Co., Ltd. Derives de la 4-hydroxy-4-phenylpiperidine et produits pharmaceutiques a base de ceux-ci
AU1816901A (en) 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity
US6486142B2 (en) 1999-12-22 2002-11-26 Merck Frosst Canada & Co. Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
US6703525B2 (en) 2000-02-16 2004-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Sulfonamide intermediates and methods of producing same
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
CA2404280A1 (fr) 2000-03-24 2002-09-23 Meiji Seika Kaisha, Ltd. Derives de la diphenylalkylamine utiles comme agonistes du recepteur de l'opioide .delta.
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
JPWO2002030896A1 (ja) 2000-10-12 2004-02-19 エスエス製薬株式会社 ２，２−ジフェニルブタンアミド誘導体及びこれを含有する医薬
WO2002038185A2 (fr) 2000-11-13 2002-05-16 Atrix Laboratories, Inc. Systeme d'administration injectable a liberation prolongee comprenant du loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
KR100886002B1 (ko) * 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법

Also Published As

Publication number Publication date
NZ572685A (en) 2010-06-25
US7687518B2 (en) 2010-03-30
NO20052894D0 (no) 2005-06-14
CR11037A (es) 2009-10-29
RS20050375A (sr) 2007-11-15
CN1711256A (zh) 2005-12-21
AU2003294313B2 (en) 2010-08-26
JP2010163452A (ja) 2010-07-29
ATE402167T1 (de) 2008-08-15
CY1107682T1 (el) 2013-04-18
DE60313021T2 (de) 2007-12-13
KR20050115221A (ko) 2005-12-07
JP4601429B2 (ja) 2010-12-22
PT1803718E (pt) 2008-09-26
TW200819436A (en) 2008-05-01
US20040152689A1 (en) 2004-08-05
EA200500726A1 (ru) 2005-10-27
CA2506242C (fr) 2011-07-05
PT1562932E (pt) 2007-07-02
AR047008A1 (es) 2006-01-04
US7202259B2 (en) 2007-04-10
DE60322451D1 (de) 2008-09-04
OA13010A (en) 2006-11-10
GEP20084539B (en) 2008-11-25
CY1108422T1 (el) 2014-04-09
DE60313021D1 (de) 2007-05-16
TW200418828A (en) 2004-10-01
IL209352A0 (en) 2011-01-31
CO5690588A2 (es) 2006-10-31
MY135647A (en) 2008-06-30
IS8913A (is) 2010-07-21
CR7877A (es) 2005-11-30
IS2720B (is) 2011-02-15
CA2506242A1 (fr) 2004-06-03
RS51047B (sr) 2010-10-31
NO20052894L (no) 2005-06-14
SG165998A1 (en) 2010-11-29
MXPA05004669A (es) 2005-06-08
EP1562932A1 (fr) 2005-08-17
ES2285235T3 (es) 2007-11-16
CN100567288C (zh) 2009-12-09
ES2312150T3 (es) 2009-02-16
EA008621B1 (ru) 2007-06-29
AU2003294313A1 (en) 2004-06-15
SI1803718T1 (sl) 2008-12-31
ECSP055840A (es) 2005-08-11
NZ540068A (en) 2007-07-27
JP2006525944A (ja) 2006-11-16
US20100069437A1 (en) 2010-03-18
EP1803718A1 (fr) 2007-07-04
HK1086829A1 (zh) 2006-09-29
IS7812A (is) 2005-04-19
DK1562932T3 (da) 2007-08-13
US8026254B2 (en) 2011-09-27
AP2210A (en) 2011-02-25
MEP48108A (en) 2011-02-10
NI200500087A (es) 2007-07-24
WO2004046132A1 (fr) 2004-06-03
AU2010246411A1 (en) 2010-12-16
MA27565A1 (fr) 2005-10-03
BR0316305A (pt) 2005-09-27
EP1803718B1 (fr) 2008-07-23
EP1562932B1 (fr) 2007-04-04
ATE358674T1 (de) 2007-04-15
SI1562932T1 (sl) 2007-08-31
EP1562932B9 (fr) 2007-09-12
US20070179141A1 (en) 2007-08-02
TWI343917B (en) 2011-06-21
CN101648941A (zh) 2010-02-17
AP2005003297A0 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
NO20052914D0 (no) Terapeutiske forbindelser
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
NO20045554L (no) Fremgangsmate for behandling av diabetes
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
NO20033804L (no) Karbamatforbindelser for behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
DK1553950T3 (da) Terapeutisk behandling
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DE60326734D1 (de) Ligations-behandlungsgerät